Lab study uses donated human tissue to speed up drug screening
NCT ID NCT07047677
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses leftover tissue from surgeries to test how experimental radiolabeled ligands bind to human cells. Researchers aim to create a platform that can quickly assess these agents without needing animal tests. The study involves 300 tissue samples and focuses on measuring how well the ligands stick to their targets.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this platform could help researchers quickly screen new imaging or therapeutic agents on real human tissue, potentially speeding up drug development.
- What could go wrong
- This is an early, lab-based study using stored tissue samples, not a treatment trial. Results may not predict how the ligands behave in living patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TISSUE MODEL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chru Nancy
RECRUITINGVandœuvre-lès-Nancy, 54511, France